Viewing Study NCT00171093


Ignite Creation Date: 2025-12-25 @ 1:10 AM
Ignite Modification Date: 2026-05-07 @ 8:42 PM
Study NCT ID: NCT00171093
Status: COMPLETED
Last Update Posted: 2017-02-23
First Post: 2005-09-10
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A 10-12 Week Study to Evaluate the Safety and Efficacy of 320 mg Valsartan and 80 mg Simvastatin in Combination and as Monotherapies in Treating Hypertension and Hypercholesterolemia
Sponsor: Novartis
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: CVAS489A2316
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators